NVVE Q2 2025 Earnings Wide Loss Reported Amidst Operational Challenges Stock Gains 69 SNAL Q1 2026 Earnings EPS Surges Past Estimates Amid Tight Cost Controls STLA Q1 2026 Earnings EPS Misses Estimates as Company Navigates Transition Challenges MGRE Q1 2026 Earnings EPS Surpasses Estimates by 094 Revenue Details Not Disclosed DORM Q1 2026 Earnings EPS Misses Estimates as Earnings Surprise Turns Negative Addex Therapeutics Q1 2024 Earnings PreRevenue Biotech Advances Pipeline Amid Narrowing Losses